BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35162151)

  • 1. Shorter Incubation Period among Unvaccinated Delta Variant Coronavirus Disease 2019 Patients in Japan.
    Ogata T; Tanaka H; Irie F; Hirayama A; Takahashi Y
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
    Ward T; Glaser A; Overton CE; Carpenter B; Gent N; Seale AC
    Epidemiol Infect; 2022 Dec; 151():e32. PubMed ID: 36535802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shorter Incubation Period among COVID-19 Cases with the BA.1 Omicron Variant.
    Tanaka H; Ogata T; Shibata T; Nagai H; Takahashi Y; Kinoshita M; Matsubayashi K; Hattori S; Taniguchi C
    Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the incubation period and generation time of SARS-CoV-2 Alpha and Delta variants from contact tracing data.
    Manica M; Litvinova M; De Bellis A; Guzzetta G; Mancuso P; Vicentini M; Venturelli F; Bisaccia E; Bento AI; Poletti P; Marziano V; Zardini A; d'Andrea V; Trentini F; Bella A; Riccardo F; Pezzotti P; Ajelli M; Giorgi Rossi P; Merler S;
    Epidemiol Infect; 2022 Dec; 151():e5. PubMed ID: 36524247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary Attack Rate, Transmission and Incubation Periods, and Serial Interval of SARS-CoV-2 Omicron Variant, Spain.
    Del Águila-Mejía J; Wallmann R; Calvo-Montes J; Rodríguez-Lozano J; Valle-Madrazo T; Aginagalde-Llorente A
    Emerg Infect Dis; 2022 Jun; 28(6):1224-1228. PubMed ID: 35393009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of mRNA COVID-19 Vaccines in Japan during the Nationwide Pandemic of the Delta Variant.
    Akaishi T; Kushimoto S; Katori Y; Sugawara N; Igarashi K; Fujita M; Kure S; Takayama S; Abe M; Kikuchi A; Ishizawa K; Abe Y; Imai H; Inaba Y; Iwamatsu-Kobayashi Y; Nishioka T; Onodera K; Ishii T
    Tohoku J Exp Med; 2022 May; 257(1):1-6. PubMed ID: 35354690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Incubation Period during the Omicron BA.5-Dominant Period in Japan.
    Ogata T; Tanaka H
    Emerg Infect Dis; 2023 Mar; 29(3):595-598. PubMed ID: 36787734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial Intervals and Incubation Periods of SARS-CoV-2 Omicron and Delta Variants, Singapore.
    Zeng K; Santhya S; Soong A; Malhotra N; Pushparajah D; Thoon KC; Yeo B; Ho ZJM; Cheng MCI
    Emerg Infect Dis; 2023 Apr; 29(4):814-817. PubMed ID: 36878009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association Between Clinical Severity and Incubation Period of SARS-CoV-2 Delta Variants: Retrospective Observational Study.
    Wang K; Luan Z; Guo Z; Ran J; Tian M; Zhao S
    JMIR Public Health Surveill; 2022 Nov; 8(11):e40751. PubMed ID: 36346940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Secondary Attack Rate among Unvaccinated Household Contacts of Coronavirus Disease 2019 Patients with Delta Variant in Japan.
    Ogata T; Tanaka H; Nozawa Y; Mukouyama K; Tanaka E; Osaki N; Noguchi E; Seo K; Wada K
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent and incubation periods of Delta, BA.1, and BA.2 variant cases and associated factors: a cross-sectional study in China.
    Li Y; Jiang X; Qiu Y; Gao F; Xin H; Li D; Qin Y; Li Z
    BMC Infect Dis; 2024 Mar; 24(1):294. PubMed ID: 38448822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the incubation period of COVID-19 in Vietnam.
    Bui LV; Nguyen HT; Levine H; Nguyen HN; Nguyen TA; Nguyen TP; Nguyen TT; Do TTT; Pham NT; Bui MH
    PLoS One; 2020; 15(12):e0243889. PubMed ID: 33362233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incubation Period of COVID-19 Caused by Unique SARS-CoV-2 Strains: A Systematic Review and Meta-analysis.
    Wu Y; Kang L; Guo Z; Liu J; Liu M; Liang W
    JAMA Netw Open; 2022 Aug; 5(8):e2228008. PubMed ID: 35994285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-Varying Susceptibility to the Delta Variant (B.1.617.2) of SARS-CoV-2.
    Chun JY; Jeong H; Kim Y
    JAMA Netw Open; 2022 Mar; 5(3):e223064. PubMed ID: 35302625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Secondary Attack Rates among the Household Contacts of Patients with the Omicron Variant of the Coronavirus Disease 2019 in Japan.
    Ogata T; Tanaka H; Tanaka E; Osaki N; Noguchi E; Osaki Y; Tono A; Wada K
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of incubation periods of infections of Omicron variants BA.2 and BF.7 in Beijing].
    Xu X; Cai YX; Liu YH; Shen Y; Pan Y; Yao H; Wang XL; Yang P
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Sep; 44(9):1397-1401. PubMed ID: 37743272
    [No Abstract]   [Full Text] [Related]  

  • 17. SARS-Cov-2 incubation period according to vaccination status during the fifth COVID-19 wave in a tertiary-care center in Spain: a cohort study.
    Cortés Martínez J; Pak D; Abelenda-Alonso G; Langohr K; Ning J; Rombauts A; Colom M; Shen Y; Gómez Melis G
    BMC Infect Dis; 2022 Nov; 22(1):828. PubMed ID: 36352359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of incubation period of infection with 2019-nCoV Omicron variant BA.5.1.3].
    Li WX; Cao L; Zhang DH; Cai C; Huang LJ; Zhao JN; Ning Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Mar; 44(3):367-372. PubMed ID: 36942329
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation between times to SARS-CoV-2 symptom onset and secondary transmission undermines epidemic control efforts.
    Linton NM; Akhmetzhanov AR; Nishiura H
    Epidemics; 2022 Dec; 41():100655. PubMed ID: 36413921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021.
    Taylor CA; Patel K; Pham H; Whitaker M; Anglin O; Kambhampati AK; Milucky J; Chai SJ; Kirley PD; Alden NB; Armistead I; Meek J; Yousey-Hindes K; Anderson EJ; Openo KP; Teno K; Weigel A; Monroe ML; Ryan PA; Henderson J; Nunez VT; Bye E; Lynfield R; Poblete M; Smelser C; Barney GR; Spina NL; Bennett NM; Popham K; Billing LM; Shiltz E; Abdullah N; Sutton M; Schaffner W; Talbot HK; Ortega J; Price A; Garg S; Havers FP;
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(43):1513-1519. PubMed ID: 34710076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.